{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:08:40Z","timestamp":1791454120122,"version":"4.3.3"},"reference-count":102,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008307","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T20:07:27Z","timestamp":1598558847000},"page":"e0008307","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects"],"prefix":"10.1371","volume":"14","author":[{"given":"Lamis Y. M.","family":"Elkheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Haroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-6408","authenticated-orcid":true,"given":"Magdi Awadalla","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-7321","authenticated-orcid":true,"given":"Ahmed Hassan","family":"Fahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"pntd.0008307.ref001","unstructured":"WHO | Mycetoma. WHO. World Health Organization; 2016; Available: https:\/\/www.who.int\/buruli\/mycetoma\/en\/"},{"key":"pntd.0008307.ref002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/ijd.IJD_476_16","article-title":"Mycetoma: An Update","volume":"62","author":"V Relhan","year":"2017","journal-title":"Indian J Dermatol"},{"key":"pntd.0008307.ref003","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/jdv.13008","article-title":"Eumycetoma and actinomycetoma\u2014an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy","volume":"29","author":"P Nenoff","year":"2015","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"pntd.0008307.ref004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1473-3099(04)01131-4","article-title":"Mycetoma caused by Madurella mycetomatis: a neglected infectious burden","volume":"4","author":"AO Ahmed","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"pntd.0008307.ref005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0035-9203(03)00009-9","article-title":"Mycetoma: a thorn in the flesh","volume":"98","author":"AH Fahal","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008307.ref006","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/B978-0-7020-3935-5.00083-5","volume-title":"Mycetoma. Tropical Infectious Diseases: Principles, Pathogens and Practice","author":"AH Fahal","year":"2011"},{"key":"pntd.0008307.ref007","first-page":"64","volume-title":"Bailey and Love\u2019s Short Practice of Surgery","author":"A Fahal","year":"2013","edition":"26"},{"key":"pntd.0008307.ref008","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clindermatol.2011.06.027","article-title":"Actinomycetoma and advances in its treatment","volume":"30","author":"O Welsh","year":"2012","journal-title":"Clin Dermatol"},{"key":"pntd.0008307.ref009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1586\/edm.09.67","article-title":"Management of mycetoma","volume":"5","author":"AH Fahal","year":"2010","journal-title":"Expert Rev Dermatol"},{"key":"pntd.0008307.ref010","doi-asserted-by":"crossref","first-page":"e3218","DOI":"10.1371\/journal.pntd.0003218","article-title":"Mycetoma medical therapy","volume":"8","author":"O Welsh","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref011","doi-asserted-by":"crossref","first-page":"e2918","DOI":"10.1371\/journal.pntd.0002918","article-title":"Merits and pitfalls of currently used diagnostic tools in mycetoma","volume":"8","author":"WWJ van de Sande","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref012","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2214\/ajr.180.3.1800665","article-title":"New Radiographic Classification of Bone Involvement in Pedal Mycetoma","volume":"180","author":"ME Abd El Bagi","year":"2003","journal-title":"Am J Roentgenol"},{"key":"pntd.0008307.ref013","first-page":"529","article-title":"Mycetoma revisited. Incidence of various radiographic signs","volume":"30","author":"ME Abd El-Bagi","year":"2009","journal-title":"Saudi Med J"},{"key":"pntd.0008307.ref014","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/bjs.1800840824","article-title":"Ultrasonographic imaging of mycetoma","volume":"84","author":"AH Fahal","year":"1997","journal-title":"Br J Surg"},{"key":"pntd.0008307.ref015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.trstmh.2012.08.009","article-title":"New MRI grading system for the diagnosis and management of mycetoma","volume":"106","author":"ME EL Shamy","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008307.ref016","doi-asserted-by":"crossref","first-page":"e0005638","DOI":"10.1371\/journal.pntd.0005638","article-title":"Mycetoma laboratory diagnosis: Review article","volume":"11","author":"AA Ahmed","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref017","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JCM.00862-06","article-title":"Molecular identification of black-grain mycetoma agents","volume":"44","author":"M Desnos-Ollivier","year":"2006","journal-title":"J Clin Microbiol"},{"key":"pntd.0008307.ref018","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/JCM.37.10.3175-3178.1999","article-title":"Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis","volume":"37","author":"AO Ahmed","year":"1999","journal-title":"J Clin Microbiol"},{"key":"pntd.0008307.ref019","doi-asserted-by":"crossref","first-page":"e0004690","DOI":"10.1371\/journal.pntd.0004690","article-title":"The Surgical Treatment of Mycetoma","volume":"10","author":"SH Suleiman","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-0960.1993.tb00844.x","article-title":"Treatment of eumycetoma with ketoconazole","volume":"34","author":"V Venugopal P","year":"1993","journal-title":"Australas J Dermatol"},{"key":"pntd.0008307.ref021","first-page":"191","article-title":"Clinical cure of fungal madura foot with oral itraconazole.","volume":"60","author":"A Paugam","year":"1997","journal-title":"Cutis"},{"key":"pntd.0008307.ref022","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2133.2005.06534.x","article-title":"Madurella mycetomatis mycetoma treated successfully with oral voriconazole","volume":"152","author":"C Lacroix","year":"2005","journal-title":"Br J Dermatol"},{"key":"pntd.0008307.ref023","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4269\/ajtmh.2006.75.1106","article-title":"Successful treatment of black-grain mycetoma with voriconazole","volume":"75","author":"P Loulergue","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008307.ref024","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"R Negroni","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"pntd.0008307.ref025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4632.2004.02392.x","article-title":"Clinical efficacy and safety of oral terbinafine in fungal mycetoma","volume":"45","author":"B N\u2019Diaye","year":"2006","journal-title":"Int J Dermatol"},{"key":"pntd.0008307.ref026","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"pntd.0008307.ref027","doi-asserted-by":"crossref","first-page":"e0005301","DOI":"10.1371\/journal.pntd.0005301","article-title":"Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil","volume":"11","author":"FMS Sampaio","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref028","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-4632.2008.03447.x","article-title":"Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from S\u00e3o Paulo, Brazil","volume":"47","author":"LGM Castro","year":"2008","journal-title":"Int J Dermatol"},{"key":"pntd.0008307.ref029","article-title":"Unusual extra-podal fungal mycetoma with black grains in a Senegalese child","author":"B Seck","year":"2019","journal-title":"J Mycol Med"},{"key":"pntd.0008307.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2017.1270264","article-title":"Clinical hepatotoxicity associated with antifungal agents","volume":"16","author":"I Kyriakidis","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"pntd.0008307.ref031","unstructured":"FDA. FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems | FDA [Internet]. [cited 29 May 2019]. Available: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially"},{"key":"pntd.0008307.ref032","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0035-9203(84)90126-3","article-title":"Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii","volume":"78","author":"ES Mahgoub","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008307.ref033","first-page":"163","article-title":"Value of ketoconazole in combination with the surgical treatment of fungal mycetoma","volume":"112","author":"JM Andreu","year":"1986","journal-title":"Chirurgie"},{"key":"pntd.0008307.ref034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"Rahman MEAEL, Zijlstra EE. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"AH Fahal","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008307.ref035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trstmh.2012.07.003","article-title":"Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"106","author":"HAM Zein","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008307.ref036","doi-asserted-by":"crossref","first-page":"e0005007","DOI":"10.1371\/journal.pntd.0005007","article-title":"Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience","volume":"10","author":"A Wadal","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref037","doi-asserted-by":"crossref","first-page":"e0003679","DOI":"10.1371\/journal.pntd.0003679","article-title":"Mycetoma in the Sudan: An Update from the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"9","author":"A Fahal","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref038","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole","volume":"357","author":"SR Ahmad","year":"2001","journal-title":"Lancet"},{"key":"pntd.0008307.ref039","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0253-7613.117751","article-title":"Heart failure induced by itraconazole","volume":"45","author":"H Okuyan","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"pntd.0008307.ref040","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1016\/j.ijcard.2013.12.057","article-title":"Congestive heart failure related to antifungal therapy with itraconazole","volume":"172","author":"R Vollenbroich","year":"2014","journal-title":"Int J Cardiol"},{"key":"pntd.0008307.ref041","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/dku355","article-title":"Antifungal drugs during pregnancy: an updated review","volume":"70","author":"B Pilmis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0008307.ref042","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00002018-200932030-00006","article-title":"First-Trimester Itraconazole Exposure and Pregnancy Outcome","volume":"32","author":"M De Santis","year":"2009","journal-title":"Drug Saf"},{"key":"pntd.0008307.ref043","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay","volume":"48","author":"AOA Ahmed","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref044","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","article-title":"Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method","volume":"49","author":"WWJ van de Sande","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref045","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2165\/00003495-200464180-00001","article-title":"Newer Systemic Antifungal Agents","volume":"64","author":"HW Boucher","year":"2004","journal-title":"Drugs"},{"key":"pntd.0008307.ref046","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.32.9.1310","article-title":"Pharmacokinetics of itraconazole following oral administration to normal volunteers","volume":"32","author":"TC Hardin","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref047","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002280050280","article-title":"Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole","volume":"52","author":"S Jaruratanasirikul","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"pntd.0008307.ref048","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00558308","article-title":"The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects","volume":"36","author":"A Van Peer","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"pntd.0008307.ref049","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.37.4.778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers","volume":"37","author":"JA Barone","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-199835060-00004","article-title":"Optimisation of Itraconazole Therapy Using Target Drug Concentrations","volume":"35","author":"M Poirier","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"pntd.0008307.ref051","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dki220","article-title":"Making sense of itraconazole pharmacokinetics","volume":"56","author":"AG Prentice","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0008307.ref052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200161001-00003","article-title":"Pharmacology of Itraconazole","volume":"61","author":"K De Beule","year":"2001","journal-title":"Drugs"},{"key":"pntd.0008307.ref053","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents","volume":"48","author":"RJM Br\u00fcggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"pntd.0008307.ref054","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(99)70055-1","article-title":"Drug interactions with itraconazole, fluconazole, and terbinafine and their management","volume":"41","author":"AK Gupta","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"pntd.0008307.ref055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12281-008-0004-4","article-title":"Pharmacokinetic drug interactions of azoles","volume":"2","author":"RJM Br\u00fcggemann","year":"2008","journal-title":"Curr Fungal Infect Rep"},{"key":"pntd.0008307.ref056","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2710.2005.00632.x","article-title":"Reduced oral itraconazole bioavailability by antacid suspension","volume":"30","author":"M Lohitnavy","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"pntd.0008307.ref057","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/j.1552-4604.1997.tb04332.x","article-title":"Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H 2 Blockers","volume":"37","author":"D Lange","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"pntd.0008307.ref058","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050438","article-title":"Effect of omeprazole on the pharmacokinetics of itraconazole","volume":"54","author":"S Jaruratanasirikul","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"pntd.0008307.ref059","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450","volume":"15","author":"T Niwa","year":"2014","journal-title":"Curr Drug Metab"},{"key":"pntd.0008307.ref060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/dmd.111.042739","article-title":"Stereospecific Metabolism of Itraconazole by CYP3A4: Dioxolane Ring Scission of Azole Antifungals","volume":"40","author":"C-C Peng","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"pntd.0008307.ref061","doi-asserted-by":"crossref","first-page":"149S","DOI":"10.1592\/phco.21.12.149S.34505","article-title":"Rationale for combination antifungal therapy","volume":"21","author":"RE Lewis","year":"2001","journal-title":"Pharmacotherapy"},{"key":"pntd.0008307.ref062","doi-asserted-by":"crossref","first-page":"451","DOI":"10.14740\/jocmr2992w","article-title":"Combination Antifungal Therapy: A Review of Current Data","volume":"9","author":"M Campitelli","year":"2017","journal-title":"J Clin Med Res"},{"key":"pntd.0008307.ref063","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mycmed.2017.09.004","article-title":"Challenges in culture-negative cases of Madurella mycetomatis: A case report re-accentuating PCR as an essential diagnostic tool","volume":"27","author":"S K","year":"2017","journal-title":"J Mycol Med"},{"key":"pntd.0008307.ref064","doi-asserted-by":"crossref","first-page":"e3232","DOI":"10.1371\/journal.pntd.0003232","article-title":"Last generation triazoles for imported eumycetoma in eleven consecutive adults","volume":"8","author":"Y Crabol","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"A Vermes","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0008307.ref066","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mycmed.2016.03.003","article-title":"Role of a NSAID in the apparent cure of a fungal mycetoma","volume":"26","author":"B Dupont","year":"2016","journal-title":"J Mycol Med"},{"key":"pntd.0008307.ref067","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JCM.36.3.850-851.1998","article-title":"Unexpected high prevalence of secondary bacterial infection in patients with mycetoma","volume":"36","author":"AO Ahmed","year":"1998","journal-title":"J Clin Microbiol"},{"key":"pntd.0008307.ref068","doi-asserted-by":"crossref","first-page":"e2959","DOI":"10.1371\/journal.pntd.0002959","article-title":"The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection","volume":"8","author":"NA Mhmoud","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref069","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4269\/ajtmh.14-0335","article-title":"Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin","volume":"91","author":"AM Sharma","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008307.ref070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-4632.2008.03447.x","article-title":"Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from S\u00e3o Paulo, Brazil","volume":"47","author":"LGM Castro","year":"2008","journal-title":"Int J Dermatol"},{"key":"pntd.0008307.ref071","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/02681219580000041","article-title":"The host tissue reaction to Madurella mycetomatis: new classification","volume":"33","author":"AH Fahal","journal-title":"J Med Vet Mycol"},{"key":"pntd.0008307.ref072","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1439-0507.1993.tb00694.x","article-title":"Mycetoma: a retrospective study of 41 cases seen in S\u00e3o Paulo, Brazil, from 1978 to 1989","volume":"36","author":"LG Castro","journal-title":"Mycoses"},{"key":"pntd.0008307.ref073","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/AAC.01170-12","article-title":"In vitro antifungal activity of isavuconazole against Madurella mycetomatis","volume":"56","author":"W Kloezen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref074","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pntd.0002942","article-title":"Madurella mycetomatis is highly susceptible to ravuconazole","volume":"8","author":"SA Ahmed","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref075","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay","volume":"48","author":"AOA Ahmed","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref076","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.01045-10","article-title":"In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine","volume":"55","author":"A van Belkum","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref077","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.micinf.2007.05.015","article-title":"Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole","volume":"9","author":"WWJ van de Sande","year":"2007","journal-title":"Microbes Infect"},{"key":"pntd.0008307.ref078","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1128\/AAC.04917-14","article-title":"Melanin Protects Paracoccidioides brasiliensis from the Effects of Antimicrobial Photodynamic Inhibition and Antifungal Drugs","volume":"59","author":"LM Baltazar","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref079","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetimm.2008.04.020","article-title":"Immune response to fungal infections","volume":"125","author":"JL Blanco","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"pntd.0008307.ref080","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1128\/AAC.02190-15","article-title":"Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs","volume":"60","author":"C Fernandes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref081","doi-asserted-by":"crossref","first-page":"e2754","DOI":"10.1371\/journal.pntd.0002754","article-title":"Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma","volume":"8","author":"K Geneugelijk","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref082","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"PA Netti","year":"2000","journal-title":"Cancer Res"},{"key":"pntd.0008307.ref083","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1096\/fj.07-9150com","article-title":"Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin","volume":"22","author":"M Magzoub","year":"2008","journal-title":"FASEB J"},{"key":"pntd.0008307.ref084","doi-asserted-by":"crossref","first-page":"e2400","DOI":"10.1371\/journal.pntd.0002400","article-title":"Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience","volume":"7","author":"EA Ezaldeen","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref085","unstructured":"Safi A. TRADITIONAL SUDANESE MEDICINE A primer for health care providers, researchers, and students [Internet]. 1st ed. 2006. Available: https:\/\/www.academia.edu\/7994190\/TRADITIONAL_SUDANESE_MEDICINE_A_primer_for_health_care_providers_researchers_and_students"},{"key":"pntd.0008307.ref086","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.04487-14","article-title":"In vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis","volume":"59","author":"SA Ahmed","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref087","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/tmi.12871","article-title":"Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis","volume":"22","author":"K Eadie","year":"2017","journal-title":"Trop Med Int Heal"},{"key":"pntd.0008307.ref088","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coi.2017.07.012","article-title":"Organoid culture systems to study host\u2013pathogen interactions","volume":"48","author":"D Dutta","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"pntd.0008307.ref089","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-pharmtox-010818-021108","article-title":"Organoids for Drug Discovery and Personalized Medicine","volume":"59","author":"T. Takahashi","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"pntd.0008307.ref090","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"HR Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0008307.ref091","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","article-title":"Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics","volume":"26","author":"L Willems","year":"2001","journal-title":"J Clin Pharm Ther"},{"key":"pntd.0008307.ref092","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1128\/AAC.42.7.1862","article-title":"Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers","volume":"42","author":"JA Barone","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008307.ref093","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.trci.2017.10.005","article-title":"Drug discovery and development: Role of basic biological research","volume":"3","author":"RC Mohs","year":"2017","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"pntd.0008307.ref094","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","article-title":"Repurposing strategies for tropical disease drug discovery","volume":"26","author":"DM Klug","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"pntd.0008307.ref095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug Repurposing: Far Beyond New Targets for Old Drugs","volume":"14","author":"TI Oprea","year":"2012","journal-title":"AAPS J"},{"key":"pntd.0008307.ref096","first-page":"176","article-title":"The worlds most neglected diseases. Ignored by the pharmaceutical industry and by public-private partnerships [editorial]","volume":"325","author":"Y G","year":"2002","journal-title":"BMJ Br Med J"},{"key":"pntd.0008307.ref097","doi-asserted-by":"crossref","first-page":"e0004244","DOI":"10.1371\/journal.pntd.0004244","article-title":"Mycetoma: A Long Journey from Neglect","volume":"10","author":"EE Zijlstra","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref098","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nrd2961","article-title":"Lessons from 60 years of pharmaceutical innovation","volume":"8","author":"B. Munos","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"pntd.0008307.ref099","first-page":"175","article-title":"Drug discovery and development for neglected diseases: the DNDi model","volume":"5","author":"E Chatelain","year":"2011","journal-title":"Drug Des Devel Ther"},{"key":"pntd.0008307.ref100","doi-asserted-by":"crossref","first-page":"e0006437","DOI":"10.1371\/journal.pntd.0006437","article-title":"Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma","volume":"12","author":"W Lim","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008307.ref101","unstructured":"DNDi. MycetOS [Internet]. 2018 [cited 19 Jun 2019]. Available: https:\/\/www.dndi.org\/diseases-projects\/open-innovation\/mycetos\/"},{"key":"pntd.0008307.ref102","doi-asserted-by":"crossref","first-page":"e1002276","DOI":"10.1371\/journal.pmed.1002276","article-title":"An open source pharma roadmap","volume":"14","author":"M Balasegaram","year":"2017","journal-title":"PLoS Med"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T20:07:58Z","timestamp":1598558878000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008307"}},"subtitle":[],"editor":[{"given":"Abdallah M.","family":"Samy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":102,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008307","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}